Khiron Life Sciences (KHRN.V) wisely spent 2018 laying the groundwork for its continued expansion throughout the Americas. As Abraham Lincoln once said, “Give me six hours to chop down a tree and I will spend the first four sharpening the ax.”

With two separate deals granting access to the U.S. and Brazilian markets, Khiron is well positioned to supply the burgeoning demand for cannabis on this side of the Atlantic and beyond.

Equity.Guru’s Ethan Reyes spoke with Khiron president, Chris Naprawa, to discuss the company’s progress in 2018, the tantalizing Brazilian market and what the sector can expect from Khiron in 2019.

Full disclosure: Khiron Life Sciences is an Equity.Guru marketing client.

Written By:

Ethan Reyes

More By This Author